Significant Accounting Policies (Tables)
|
12 Months Ended |
Jun. 30, 2020 |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] |
|
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] |
| | | | | | | | | | For the Years Ended June 30, | | | 2020 | | 2019 | Stock options | | 157,000 |
| | 213,000 |
| Convertible preferred stock | | 5,118,060 |
| | 4,773,120 |
| Total potential dilutive securities not included in income per share | | 5,275,060 |
| | 4,986,120 |
|
Earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the year. All outstanding stock options are considered potential common stock. All outstanding convertible preferred stock are considered common stock at the beginning of the period or at the time of issuance, if later, pursuant to the if-converted method. The dilutive effect, if any, of stock options is calculated using the treasury stock method. As of June 30, 2020 and 2019, the average market prices for the years then ended are less than the exercise price of all the outstanding stock options and, therefore, the inclusion of the stock options would be anti-dilutive. In addition, since the effect of common stock equivalents is anti-dilutive with respect to losses, the convertible preferred stock has also been excluded from the Company’s computation of loss per common for the years ended June 30, 2020 and 2019. Therefore, basic and diluted loss per common share for the years ended June 30, 2020 and 2019 are the same. | | | | | | | | | | | | | For the Years Ended June 30, | | | 2020 | | 2019 | Numerator: | | | | | Numerator for basic loss per share: | | | | | Net loss | | $ | (650,280 | ) | | $ | (250,016 | ) | Undeclared dividends on preferred stock | | 51,741 |
| | 51,600 |
| Net loss applicable to common shareholders | | $ | (702,021 | ) | | $ | (301,616 | ) | Numerator for diluted earnings per share: | | | | | Net loss applicable to common shareholders | | $ | (702,021 | ) | | $ | (301,616 | ) | Undeclared dividends on preferred stock | | — |
| | — |
| Net loss | | $ | (650,280 | ) | | $ | (301,616 | ) | Denominator: | | | | | Denominator for basic loss per share - weighted average shares outstanding
| | 7,415,329 |
| | 7,415,329 |
| Weighted average preferred stock converted to common stock | | — |
| | — |
| Denominator for diluted loss per share - weighted average and assumed conversion | | 7,415,329 |
| — |
| 7,415,329 |
| Net loss per share: | | | | | Basic net loss per share | | $ | (0.09 | ) | | $ | (0.04 | ) | Diluted net loss per share | | $ | (0.09 | ) | | $ | (0.04 | ) |
The following table summarizes convertible preferred stock and securities that, if exercised would have an anti-dilutive effect on earnings per share.
|
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] |
| | | | | | | | | | | | | For the Years Ended June 30, | | | 2020 | | 2019 | Numerator: | | | | | Numerator for basic loss per share: | | | | | Net loss | | $ | (650,280 | ) | | $ | (250,016 | ) | Undeclared dividends on preferred stock | | 51,741 |
| | 51,600 |
| Net loss applicable to common shareholders | | $ | (702,021 | ) | | $ | (301,616 | ) | Numerator for diluted earnings per share: | | | | | Net loss applicable to common shareholders | | $ | (702,021 | ) | | $ | (301,616 | ) | Undeclared dividends on preferred stock | | — |
| | — |
| Net loss | | $ | (650,280 | ) | | $ | (301,616 | ) | Denominator: | | | | | Denominator for basic loss per share - weighted average shares outstanding
| | 7,415,329 |
| | 7,415,329 |
| Weighted average preferred stock converted to common stock | | — |
| | — |
| Denominator for diluted loss per share - weighted average and assumed conversion | | 7,415,329 |
| — |
| 7,415,329 |
| Net loss per share: | | | | | Basic net loss per share | | $ | (0.09 | ) | | $ | (0.04 | ) | Diluted net loss per share | | $ | (0.09 | ) | | $ | (0.04 | ) |
The following table summarizes convertible preferred stock and securities that, if exercised would have an anti-dilutive effect on earnings per share.
| | | | | | | | | | For the Years Ended June 30, | | | 2020 | | 2019 | Stock options | | 157,000 |
| | 213,000 |
| Convertible preferred stock | | 5,118,060 |
| | 4,773,120 |
| Total potential dilutive securities not included in income per share | | 5,275,060 |
| | 4,986,120 |
|
|
Deferred Revenue, by Arrangement, Disclosure [Table Text Block] |
| | | | | | | | | | | | Years ended June 30, | | | 2020 | | 2019 | Beginning of Year | | $ | 427,000 |
| | $ | 481,000 |
| Additions | | 1,052,000 |
| | 888,000 |
| Revenue Recognized | | 963,000 |
| | 942,000 |
| End of Year | | $ | 516,000 |
| | $ | 427,000 |
|
|